Standout Papers

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACT... 2013 2026 2017 2021 480
  1. Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial (2013)
    Cem Gabay, Paul Emery et al. The Lancet

Immediate Impact

1 by Nobel laureates 15 from Science/Nature 68 standout
Sub-graph 1 of 17

Citing Papers

GZMK-expressing CD8+ T cells promote recurrent airway inflammatory diseases
2025 StandoutNature
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
2 intermediate papers

Works of Ara Dikranian being referenced

Tocilizumab monotherapy versus adalimumab monotherapy for treatment of rheumatoid arthritis (ADACTA): a randomised, double-blind, controlled phase 4 trial
2013 Standout

Author Peers

Author Last Decade Papers Cites
Ara Dikranian 564 296 188 335 17 885
Antonio Sánchez 666 333 152 243 19 975
Agnes L. Maier 624 356 214 281 22 1.1k
Charles Ludivico 729 349 226 264 13 986
J Pazdur 619 293 154 211 22 896
B. Combe 627 244 151 298 22 942
M. C. Genovese 621 314 160 223 36 821
Z Domljan 652 299 104 296 18 1.1k
Christina Dickson 658 269 168 205 13 876
Ying Zhang 702 350 155 241 15 1.0k
Anders Gülfe 817 279 116 379 20 1.1k

All Works

Loading papers...

Rankless by CCL
2026